2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
115 hedge funds and large institutions have $183M invested in 2seventy bio in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 30 reducing their positions, and 20 closing their positions.
2,436% more call options, than puts
Call options by funds: $1.06M | Put options by funds: $42K
23% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 30
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
2% less funds holding
Funds holding: 117 → 115 (-2)
27% less capital invested
Capital invested by funds: $251M → $183M (-$67.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$11.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.95M |
| 3 |
F1I
Fund 1 Investments
Rincon,
Puerto Rico
|
+$1.75M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.01M |
| 5 |
VM
Venator Management
Pittsburgh,
Pennsylvania
|
+$721K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.63M |
| 2 |
Morgan Stanley
New York
|
-$4.9M |
| 3 |
JP Morgan Chase
New York
|
-$1.94M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.35M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.21M |
TSVT Hedge Fund Activity: Q2 2024 in Review
115 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2024, worth a combined $183M — down 27% from $251M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of TSVT and 19 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 37 added.
The largest buyer was Newtyn Management, opening a new position worth an estimated $11.2M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $8.63M sold.
- 115 institutional investors held 2seventy bio (TSVT) as of Q2 2024, down from 117 in Q1 2024.
- Funds reported $183M of 2seventy bio stock for Q2 2024, down 27% quarter-over-quarter.
- 19 funds opened new 2seventy bio positions in Q2 2024 and 20 closed out, a net change of -1 holder.
- The largest 2seventy bio buyer in Q2 2024 was Newtyn Management, an estimated $11.2M added.
- The largest 2seventy bio seller in Q2 2024 was Point72 Asset Management, an estimated $8.63M sold.
Based on aggregated 13F filings for Q2 2024.